Import unapproved medicine into United States

Importing medicines into United States

View English version

Importing Unapproved Life-Saving Medicine for Personal Use into the United States

The Federal Food, Drug, and Cosmetic Act (FD&C Act) of 1938 establishes the legal framework for regulating the importation of drugs into the United States. Under this act, the importation of unapproved medications is generally prohibited to ensure the safety and efficacy of pharmaceuticals available to the public. However, recognizing the critical needs of individuals facing life-threatening conditions without effective domestic treatments, the U.S. Food and Drug Administration (FDA) has policies that may allow the importation of unapproved, life-saving medicines for personal use under specific circumstances.

Understanding the FD&C Act Regulations

The FD&C Act mandates that all drugs marketed in the United States must be approved by the FDA. This approval process requires rigorous evaluation of a drug's safety, efficacy, and manufacturing quality. Importing unapproved drugs bypasses these safeguards and poses potential risks to public health. Therefore, the FDA strictly regulates the importation of medications to protect consumers from unsafe or ineffective products.

Despite these restrictions, the FDA acknowledges situations where individuals may require access to unapproved medications for serious conditions when no satisfactory alternatives are available domestically. In such cases, the FDA's enforcement discretion may allow for personal importation under defined criteria.

Criteria for Personal Importation of Unapproved Medicines

According to the FDA's Personal Importation Policy, individuals may be allowed to import unapproved medications for personal use if the following conditions are met:

Serious Medical Condition: The drug is intended for use in the treatment of a serious condition for which effective treatment is not available in the United States.
No Commercialization: The drug is not promoted or commercialized to U.S. residents by those involved in distribution.
Personal Use: The quantity is generally not more than a three-month supply and is intended solely for the importer's personal use.
Risk Assessment: The drug does not pose an unreasonable risk to the user.
Documentation: The individual seeking to import the drug affirms in writing that it is for personal use and provides the name and address of the licensed U.S. physician overseeing the treatment.

Meeting these criteria does not guarantee that the FDA will allow the importation, but it provides a basis for the agency to exercise discretion.

Steps to Import Life-Saving Medicine

Individuals considering the importation of an unapproved life-saving medication should carefully follow these steps to comply with FDA regulations and increase the likelihood of approval:

1. Consult with a Licensed U.S. Physician

Engage with a healthcare professional licensed in the United States who is knowledgeable about the condition and the proposed treatment. The physician should be willing to oversee the treatment and monitor the patient's progress.

The physician's involvement is crucial for several reasons:

They can provide a professional assessment of the necessity of the unapproved medication.
They ensure appropriate medical supervision during treatment.
They serve as a point of contact for the FDA if additional information is required.

2. Obtain a Valid Prescription and Medical Justification

A prescription from the licensed physician is necessary. Additionally, a letter outlining the medical necessity of the unapproved medication should be prepared. The letter should include:

A confirmation of the diagnosis and the severity of the condition.
Evidence that no effective FDA-approved treatments are available domestically.
An explanation of why the unapproved medication is essential for the patient's treatment.

This documentation supports the personal importation request by establishing the critical need for the medication.

3. Prepare a Personal Statement

The individual must provide a written statement affirming that the medication is for personal use. The statement should include:

A declaration of personal use and the absence of intent to distribute the medication.
Consent to provide any additional information the FDA may require.
Contact information for both the individual and the supervising physician.

4. Ensure Compliance with Quantity Limits

The FDA typically allows importation of no more than a three-month supply of the medication. Quantities exceeding this limit may raise concerns about potential distribution or misuse.

5. Verify the Source of the Medication

The medication should be obtained from a reputable source, such as a licensed pharmacy or manufacturer in the country of origin. This helps mitigate risks associated with counterfeit or substandard products.

6. Contact the FDA for Assistance

While not explicitly required, contacting the FDA's Division of Import Operations can provide guidance and clarify any uncertainties regarding the importation process. The FDA may offer advice on additional documentation or procedures to facilitate compliance.

Contact information: Contact FDA About Imports and Exports

7. Coordinate with the Shipping Carrier

When arranging for the shipment of the medication, ensure that the carrier is aware of all regulatory requirements. Provide all necessary documentation to avoid delays or refusals at the border.

Customs Considerations and Border Entry

The U.S. Customs and Border Protection (CBP) enforces import regulations alongside the FDA. Medications entering the United States are subject to inspection, and failure to comply with regulations may result in detention or seizure of the medication.

To facilitate smooth processing:

Include all documentation with the shipment, readily accessible for inspection.
Clearly mark the package as containing medication for personal use.
Respond promptly to any inquiries from CBP or FDA officials.

Information on CBP policies can be found here: CBP Restricted and Prohibited Items

Potential Risks and Legal Implications

Importing unapproved medications carries inherent risks:

Legal Risks

Non-compliance with the FD&C Act and related regulations can result in legal actions, including fines or penalties. Unauthorized importation may be considered a violation of federal law.

Health Risks

Medications obtained from foreign sources may not meet U.S. safety standards. There is a risk of receiving counterfeit, contaminated, or improperly labeled products, which can pose significant health hazards.

Seizure of Medication

The FDA or CBP may detain or refuse entry of the medication. This could delay treatment or leave the individual without necessary medication.

Alternatives to Personal Importation

Before pursuing personal importation, consider the following alternatives that may provide access to needed medications while minimizing legal and safety risks:

1. Expanded Access Programs

The FDA's Expanded Access Program, also known as "Compassionate Use," allows patients with serious or life-threatening conditions to access investigational drugs outside of clinical trials when no comparable or satisfactory alternative therapies are available.

Under this program:

The patient’s physician must determine that the potential benefit justifies the potential risks.
The drug's manufacturer must agree to provide the investigational drug.
The FDA must authorize the use through an application process.

2. Clinical Trials

Participating in clinical trials may provide access to new treatments. Clinical trials are research studies involving patient volunteers to test new medical interventions.

Patients can search for relevant clinical trials at ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted worldwide.

3. Investigational Drug Applications

Physicians can submit an Investigational New Drug (IND) application to the FDA on behalf of a patient to request the use of an unapproved medication. This pathway is more complex and typically involves extensive documentation and compliance requirements.

Case Examples and Precedents

Understanding previous instances where individuals have successfully imported unapproved medications can provide valuable insights:

Case Study: Importation of Experimental Cancer Medication

An individual diagnosed with a rare form of cancer with no effective treatment options in the United States sought to import an experimental medication approved in another country. By collaborating with a U.S. oncologist and providing comprehensive documentation, the individual obtained FDA approval under the Personal Importation Policy.

Key factors contributing to success included:

Clearly demonstrated medical necessity.
Active involvement of a licensed U.S. physician.
Adherence to all regulatory requirements and prompt communication with authorities.

Case Study: Rejection Due to Non-Compliance

In contrast, an individual attempted to import a non-FDA-approved medication without proper documentation or physician oversight. The shipment was detained by CBP, and the medication was ultimately refused entry. The lack of compliance with importation policies resulted in legal warnings and potential penalties.

Best Practices for Compliance

To enhance the likelihood of a successful importation:

Documentation: Ensure all paperwork is thorough, accurate, and submitted in a timely manner.
Communication: Maintain open lines of communication with the FDA, CBP, and healthcare providers.
Legal Consultation: Consider consulting with legal experts specializing in FDA regulations and import laws.
Stay Informed: Keep up-to-date with any changes in policies or regulations that may affect importation procedures.

Additional Resources

For further information and assistance, the following resources are available:

Conclusion

The importation of unapproved, life-saving medicine for personal use into the United States is a complex process governed by the FD&C Act of 1938. While the default position prohibits such importation to protect public health, the FDA's policies recognize exceptions for individuals facing serious health conditions without viable domestic treatment options. By adhering strictly to the criteria outlined by the FDA, collaborating with licensed healthcare professionals, and ensuring full compliance with all regulatory requirements, individuals may navigate the importation process successfully.

It is imperative to approach this process with diligence and caution, given the potential legal and health risks involved. Utilizing available FDA programs and resources can provide alternative avenues for accessing necessary treatments while maintaining compliance with federal laws.

References

View all guides